🎉 M&A multiples are live!
Check it out!

Immatics Valuation Multiples

Discover revenue and EBITDA valuation multiples for Immatics and similar public comparables like Pharming, Julphar, and Vivoryon Therapeutics.

Immatics Overview

About Immatics

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.


Founded

2020

HQ

United States of America
Employees

680

Website

immatics.com

Financials

LTM Revenue $154M

LTM EBITDA n/a

EV

-$153M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Immatics Financials

Immatics has a last 12-month revenue of $154M and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Immatics achieved revenue of $156M and an EBITDA of $34.5M.

Immatics expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Immatics valuation multiples based on analyst estimates

Immatics P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $54.0M $156M XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$88.9M $34.5M XXX XXX XXX
EBITDA Margin -165% 22% XXX XXX XXX
Net Profit $37.5M -$97.0M XXX XXX XXX
Net Margin 69% -62% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Immatics Stock Performance

As of April 15, 2025, Immatics's stock price is $4.

Immatics has current market cap of $514M, and EV of -$153M.

See Immatics trading valuation data

Immatics Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
-$153M $514M XXX XXX XXX XXX $-0.26

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Immatics Valuation Multiples

As of April 15, 2025, Immatics has market cap of $514M and EV of -$153M.

Immatics's trades at -1.1x LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Immatics's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Immatics and 10K+ public comps

Immatics Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV -$153M XXX XXX XXX
EV/Revenue -1.0x XXX XXX XXX
EV/EBITDA -4.4x XXX XXX XXX
P/E 33.8x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 0.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Immatics Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Immatics Valuation Multiples

Immatics's NTM/LTM revenue growth is -41%

Immatics's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.3M for the same period.

Over next 12 months, Immatics's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Immatics's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Immatics and other 10K+ public comps

Immatics Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 189% XXX XXX XXX XXX
EBITDA Margin 22% XXX XXX XXX XXX
EBITDA Growth -139% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -19% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $0.3M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 30% XXX XXX XXX XXX
R&D Expenses to Revenue 95% XXX XXX XXX XXX
Opex to Revenue 125% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Immatics Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Vaccines & Immunotherapies comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Immatics M&A and Investment Activity

Immatics acquired  XXX companies to date.

Last acquisition by Immatics was  XXXXXXXX, XXXXX XXXXX XXXXXX . Immatics acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Immatics

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Immatics

When was Immatics founded? Immatics was founded in 2020.
Where is Immatics headquartered? Immatics is headquartered in United States of America.
How many employees does Immatics have? As of today, Immatics has 680 employees.
Who is the CEO of Immatics? Immatics's CEO is Dr. Harpreet Singh, PhD.
Is Immatics publicy listed? Yes, Immatics is a public company listed on NAS.
What is the stock symbol of Immatics? Immatics trades under IMTX ticker.
When did Immatics go public? Immatics went public in 2020.
Who are competitors of Immatics? Similar companies to Immatics include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Immatics? Immatics's current market cap is $514M
What is the current revenue of Immatics? Immatics's last 12-month revenue is $154M.
What is the current EV/Revenue multiple of Immatics? Current revenue multiple of Immatics is -1.1x.
What is the current revenue growth of Immatics? Immatics revenue growth between 2023 and 2024 was 189%.
Is Immatics profitable? Yes, Immatics is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.